Key result
Overweight and obesity in HF are linked to ~82% lower one-year mortality versus normal or underweight.
Why the study?
While obesity appears to increase the risk of heart failure, it may paradoxically improve survival, prompting investigation of the impact of BMI on HF morbidity and mortality.
Does overweight or obesity improve survival in Iraqi patients with heart failure?
Observational (n=122)
Yes
Does overweight or obesity improve survival in Iraqi patients with heart failure?
Overweight and obese patients with heart failure demonstrated significantly better one-year survival compared to normal or underweight patients, supporting the obesity paradox in this population.
Should not yet guide weight management in HF; supports obesity paradox in this cohort but leaves open prospective validation.
BACKGROUND: Obesity and heart failure (HF) are increasingly significant contributors to illness and death worldwide. While obesity appears to increase the risk of HF, it may paradoxically improve survival. This study aimed to investigate the impact of body mass index (BMI) on the mortality and morbidity of patients with HF. METHODOLOGY: A total of 122 patients including females (n=39) and males (n=83) diagnosed with HF were admitted to two cardiac units in Basrah, Iraq. The diagnosis was made based on Framingham Heart Failure Diagnostic Criteria. The BMI, baseline hemodynamics, and medical history were recorded, while the etiology and severity of HF were assessed at enrollment. The patients were followed up prospectively for hospital admission, and survival after one year of enrollment. RESULTS: The mean age of patients with HF was 62.7 years (SD 10.25). They included based on BMI categories 49.2% of normal/underweight individuals, while 50.8% were overweight/obese. The most frequent etiology was ischemic heart disease in 63.9%. Echocardiography revealed that the prevalence of left ventricular ejection fraction (LVEF) < 50% was 62.29%. It was observed that obese/overweight patients were more likely to have diastolic HF (P=0.001), and more severe disease (P=0.014), and were more likely to be alive at the one-year mark (P=0.001) than underweight/normal ones. Furthermore, the underweight had the least favorable outcome than any of the other five BMI categories (P<0.0001). Moreover, obese/overweight individuals had higher hospitalization rates in the first six months than normal/underweight, though this was insignificant (P=0.15). CONCLUSIONS: It appears that among Iraqis with heart failure, those who are overweight or obese had better outcomes at one year compared to normal or underweight. Further studies on a larger number of HF patients, and utilizing additional anthropometric indices and cardiorespiratory fitness to validate the observation of this study are warranted.
No takes yet. Share an insight, caveat, or question.
Abdulhameed et al. (2024) conducted an observational in Heart failure (n=122). Overweight and obesity (BMI ≥ 25 kg/m2) vs. Normal weight and underweight (BMI < 25 kg/m2) was evaluated on One-year mortality (p=0.001). Overweight and obese patients with heart failure had a significantly lower one-year mortality rate (8.06%) compared to normal or underweight patients (45.00%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: